| |
Placebo (n = 166)
|
Grass AIT (n = 163)
|
|---|
| |
N (%)*
|
Events
|
N (%)*
|
Events
|
|---|
|
All
|
101 (61)
|
258
|
121 (74)
|
454
|
|
Causality
| | | | |
|
Probably related
|
11 (7)
|
23
|
73 (45)
|
184
|
|
Possibly related
|
13 (8)
|
29
|
20 (12)
|
29
|
|
Unlikely related
|
93 (56)
|
206
|
95 (58)
|
241
|
|
Severity
| | | | |
|
Mild
|
70 (42)
|
146
|
100 (61)
|
268
|
|
Moderate
|
57 (34)
|
94
|
75 (46)
|
156
|
|
Severe
|
14 (8)
|
18
|
20 (12)
|
30
|
- *Represents all subjects experiencing AE of each causality/severity; each subject could experience AEs in multiple categories of causality/severity. AE Adverse event, AIT Allergy immunotherapy tablet.
